Enrollment of diverse populations in clinical trials is associated with more equitable opportunities and improved generalizability of results.
1,2 Mistrust engendered by a long-standing track record of societal mistreatment experienced by Black, Hispanic, and Indigenous study participants is associated with underrepresentation of these groups in clinical trials.
3 Issues such as proximity to trial sites, access to transportation, and time flexibility needed to participate are also associated with these disparities.
2,4,5 Remote trials may be associated with reductions in some of these barriers.
6